Therefore, we integrated the differentially methylated genes between pCR before treatment and non-pCR after treatment, and collected the RNA-sequencing profile of 285 HER2-positive breast cancer tumors receiving neoadjuvant therapy in GSE243375 dataset for verification. The gene discussed is ERBB2; the disease is breast cancer.